New antiepileptic drugs.

被引:1
作者
Bazil C.W. [1 ]
机构
[1] Comprehensive Epilepsy Center, Columbia University College of Physicians and Surgeons, 710 West 168th Street, New York, 10032, NY
关键词
Carbamazepine; Valproic Acid; Valproate; Status Epilepticus; Gabapentin;
D O I
10.1007/s11910-001-0092-9
中图分类号
学科分类号
摘要
Finding a niche for each antiepileptic drug has become challenging as more new agents are approved. In this article, the most recent information regarding these drugs is reported, with emphasis on the agents approved in the past 10 years. The evidence clearly shows that, despite limited Food and Drug Administration indications, all drugs are useful in monotherapy, and many have broader spectrums of action. Adverse effects can also help distinguish between agents. Familiarity with this latest information will help clinicians make the best choice for each of their patients with epilepsy.
引用
收藏
页码:369 / 375
页数:6
相关论文
共 181 条
[31]  
Collins JF(2000)Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed Epilepsia 41 1364-1374
[32]  
Cramer JC(2000)The tolerability of lamotrigine in children Drug Safety 22 303-312
[33]  
Fisher R(2000)Expanding first-line therapy options for children with partial seizures Neurology 55 S30-S37
[34]  
Ben-Menachem E(2000)Adjunctive therapy with oxcarbazepine in children with partial seizures Neurology 54 2237-2244
[35]  
Marson AG(2000)The safety of rapid valproic acid infusion Epilepsia 41 1342-1345
[36]  
Kadir ZA(2000)Intravenous valproate is well tolerated in unstable patients with status epilepticus Neurology 55 722-724
[37]  
Hutton JL(2000)Intravenous valproate in pediatric patients with refractory status epilepticus Neurology 54 2188-2189
[38]  
Chadwick DW(2000)Intravenous valproic acid for myoclonic status epilepticus Neurology 54 1201-1201
[39]  
Lhatoo SD(1999)The clinical pharmacokinetics of the new antiepileptic drugs Epilepsia 40 S7-S13
[40]  
Wong IC(2000)Adding valproate to lamotrigine: a study of their pharmacokinetic interaction Neurology 55 588-591